[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100599729":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":19,"locations":19,"responsibleParty":20,"collaborators":19,"id":24,"slug":25,"hasResults":26,"nctId":27,"briefTitle":28,"officialTitle":29,"acronym":19,"eligibilityCriteria":30,"healthyVolunteers":26,"sex":31,"minAge":19,"maxAge":19,"enrollmentInfo":32,"targetDuration":19,"studyType":35,"phases":36,"briefSummary":38,"conditions":39,"keywords":19,"overallStatus":41,"whyStopped":19,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":19},{"fullName":5,"class":6},"Tanta University","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"the main patch with microneedling and topical crisaborole and two patches as control","each patient will have 3 vitiligo patches one will be treated by microneedling and topical application of crisaborole and the other 2 patches will be considered as control patches",[12],"Procedure: microneedling with topical crisaborole",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"PROCEDURE","microneedling with topical crisaborole","From each patient 3 patches will be selected The first will have microneedling and topical crisaborole and NB UVB sessions The second will have microneedling and NB UVB sessions The third will be exposed only to NB UVB sessions The microneedling sessions will be every 2 weeks for 6 sessions",[9],null,{"type":21,"investigatorFullName":22,"investigatorTitle":23,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"PRINCIPAL_INVESTIGATOR","Dina Hassan Moustafa Fahmy","Lecturer of Dermatology and Venereology","100599729","microneedling-combined-with-topical-crisaborole-2--ointment-in-treatment-of-vitiligo-100599729",false,"NCT07088276","Microneedling Combined With Topical Crisaborole 2 % Ointment in Treatment of Vitiligo.","Microneedling Combined With Topical Crisaborole 2 % Ointment in Treatment of Vitiligo. A Prospective Controlled Trial.","Inclusion Criteria:\n\n* Patients suffer from non-segmental stable vitiligo.\n* Patients who will accept to be included in the study and will sign a written consent.\n\nExclusion Criteria:\n\n* Patients with history of koebnerization or any sign of disease activity.\n* Patients with keloid tendency.\n* Patients with active infection.\n* Pregnant or lactating woman.","ALL",{"count":33,"type":34},20,"ESTIMATED","INTERVENTIONAL",[37],"NA","The goal of this clinical trial is to learn if topical crisaborole ointment works to treat vitiligo. It will also learn about the safety of the drug. The main questions it aims to answer are:\n\nCan the drug cause repigmentation of vitiligo lesions when used as topical form after microneedling? What medical problems do participants have when the drug used?\n\nParticipants will:\n\nVisit the clinic once every 2 weeks to have the microneedling sessions for 3 months. and also they will have narrow band UVB sessions two times per week.\n\nRecord any side effect they have during or after the sessions.",[40],"Vitiligo","NOT_YET_RECRUITING","2025-07-25",{"date":44,"type":45},"2025-07-30","ACTUAL",{"date":47,"type":34},"2025-08",{"date":49,"type":34},"2026-08",{"name":5,"class":6}]